Search details
1.
Prevalence of KRAS G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review.
Oncologist
; 28(11): e981-e994, 2023 Nov 02.
Article
in English
| MEDLINE | ID: mdl-37432264
2.
A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation.
Medicina (Kaunas)
; 58(12)2022 Nov 29.
Article
in English
| MEDLINE | ID: mdl-36556957
3.
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3).
Int J Cancer
; 149(11): 1935-1943, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34310714
4.
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
Br J Cancer
; 124(3): 587-594, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33154570
5.
Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306.
Ann Surg Oncol
; 27(7): 2389-2401, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32172334
6.
Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials.
Int J Cancer
; 145(2): 576-585, 2019 07 15.
Article
in English
| MEDLINE | ID: mdl-30614531
7.
[Systemic Therapy of Metastatic Colorectal Cancer]. / Onkologische Therapiekonzepte bei systemischer Metastasierung des kolorektalen Karzinoms.
Zentralbl Chir
; 144(3): 252-258, 2019 Jun.
Article
in German
| MEDLINE | ID: mdl-31167268
8.
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
Int J Cancer
; 142(5): 1047-1055, 2018 03 01.
Article
in English
| MEDLINE | ID: mdl-29047142
9.
Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research.
BMC Cancer
; 17(1): 374, 2017 05 26.
Article
in English
| MEDLINE | ID: mdl-28549417
10.
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer.
Pancreatology
; 16(4): 593-8, 2016.
Article
in English
| MEDLINE | ID: mdl-27067420
11.
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
Int J Cancer
; 137(3): 678-85, 2015 Aug 01.
Article
in English
| MEDLINE | ID: mdl-25530271
12.
Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Tumour Biol
; 36(10): 7897-906, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25953265
13.
Surrogate endpoints in second-line treatment for mCRC: a systematic literature-based analysis from 23 randomised trials.
Acta Oncol
; 54(2): 187-93, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25017379
14.
KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer.
Future Oncol
; 11(13): 1919-29, 2015.
Article
in English
| MEDLINE | ID: mdl-26161928
15.
Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer.
Tumour Biol
; 35(10): 10237-48, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25027407
16.
[Correction: Systemic Therapy of Metastatic Colorectal Cancer]. / Erratum: Onkologische Therapiekonzepte bei systemischer Metastasierung des kolorektalen Karzinoms.
Zentralbl Chir
; 144(3): e1, 2019 06.
Article
in German
| MEDLINE | ID: mdl-31525781
17.
Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group.
Int J Cancer
; 132(1): 236-45, 2013 Jan 01.
Article
in English
| MEDLINE | ID: mdl-22644776
18.
Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma.
Cancer Med
; 12(17): 17569-17580, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37496321
19.
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
J Clin Oncol
; 41(25): 4143-4153, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-37352476
20.
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.
Eur J Cancer
; 190: 112955, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37454537